<PAGE>
OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response....14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------------
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
Echocath, Inc.
------------------------------------
(Name of Issuer)
Class A Common Stock, no par value
------------------------------------
(Title of Class of Securities)
278760 10 3
------------------------------------
(CUSIP Number)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 5 Pages
<PAGE>
CUSIP NO. 278700 10 3 13G Page 2 of 5 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON - ULTRAMED, INC.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
NEW JERSEY
- --------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES BENEFI- 239,784 (1)
CIALLY OWNED BY ------------------------------------------------------------
EACH REPORTING 6 SHARED VOTING POWER
PERSON WITH 0
------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
239,784 (1)
------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
239,784
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
/ /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.96% (2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
(1) Represents shares of Class B Common Stock, each of which is entitled to
five votes on all matters upon which stockholders may vote and is
convertible into one share of Class A Common Stock.
(2) Based on 1,610,000 shares of Class A Common Stock outstanding plus the
239,783 shares of Class B Common Stock owned by the reporting person. Does
not give effect to an additional 1,260,216 outstanding shares of Class B
Common Stock which the reporting person does not beneficially own.
<PAGE>
Page 3 of 5 Pages
ITEM 1.
(a) The name of the issuer is Echocath, Inc. (the "Company").
(b) The address of the Company's principal executive offices is 4326 U.S. Route
1, Monmouth Junction, New Jersey, 08852.
ITEM 2.
(a) The name of the entity filing this statement is Ultramed, Inc.
(b) The addresses of the principal business offices of the person filing this
statement is c/o Frank Joworisak, c/o Echocath, Inc., P.O. Box 7224,
Princeton, New Jersey 08543.
(c) The person filing this statement is a citizen of the United States of
America.
(d) The title of the class of securities for which this statement is being
filed is Class B Common Stock, no par value per share ("Class B Common
Stock").
(e) The CUSIP number of the class of securities for which this statement is
being filed is 278760 10 3.
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B),
CHECK WHETHER THE PERSON FILING IS A:
Not applicable.
ITEM 4. OWNERSHIP
See the responses set forth in items (5)-(9) and (11) on page two hereof for
information relating to the reporting person's beneficial ownership of Common
Stock of the Company.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable.
<PAGE>
Page 4 of 5 Pages
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable.
ITEM 10. CERTIFICATION
Not applicable.
<PAGE>
Page 5 of 5 Pages
SIGNATURE
After reasonable inquiry and to the best knowledge and belief of the
undersigned, the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Date: February 21, 1997
---------------------------------
ULTRAMED, INC.
By: /s/ Frank Joworisak
---------------------------------------
Frank Joworisak
President
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative (other than an executive
officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
NOTE. Six copies of this statement, including all exhibits, should be
filed with Commission.
ATTENTION. INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE
FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).
